Cargando…
ACSL3–PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression
Pancreatic ductal adenocarcinoma (PDAC) is characterized by marked fibrosis and low immunogenicity, features that are linked to treatment resistance and poor clinical outcomes. Therefore, understanding how PDAC regulates the desmoplastic and immune stromal components is of great clinical importance....
Autores principales: | Rossi Sebastiano, Matteo, Pozzato, Chiara, Saliakoura, Maria, Yang, Zhang, Peng, Ren-Wang, Galiè, Mirco, Oberson, Kevin, Simon, Hans-Uwe, Karamitopoulou, Evanthia, Konstantinidou, Georgia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608806/ https://www.ncbi.nlm.nih.gov/pubmed/33127675 http://dx.doi.org/10.1126/sciadv.abb9200 |
Ejemplares similares
-
The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancer
por: Saliakoura, Maria, et al.
Publicado: (2020) -
Restriction of extracellular lipids renders pancreatic cancer dependent on autophagy
por: Saliakoura, Maria, et al.
Publicado: (2022) -
Lipid Metabolic Alterations in KRAS Mutant Tumors: Unmasking New Vulnerabilities for Cancer Therapy
por: Saliakoura, Maria, et al.
Publicado: (2023) -
PLCγ1 suppression promotes the adaptation of KRAS-mutant lung adenocarcinomas to hypoxia
por: Saliakoura, Maria, et al.
Publicado: (2020) -
Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy
por: Rossi Sebastiano, Matteo, et al.
Publicado: (2019)